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Cancer chemotherapy administration is a complex medical procedure. It requires high levels of 
competency and safety to prevent errors that may cause harm to patients and staff.
The modern era of oncology offers a wide range of treatment options for cancer patients. These novel 
chemotherapeutic and hormonal agents, targeted and immune therapies, and new combinations 
provide the opportunity to improve patient outcomes.1 To capitalise on these gains and optimise 
outcomes, safe, error-free and competent chemotherapy administration processes are crucial.
These guidelines recognise that:
•	 Oncology is a challenging field with high stakes and vulnerable patients.
•	 Chemotherapy has narrow margins of error (therapeutic index).
•	 Chemotherapy is toxic even at therapeutic doses.
•	 Chemotherapy regimens are often highly complex.
•	 Chemotherapy administration is a multidisciplinary process.
Aims
These guidelines are a resource document with high aims. They were developed to encourage and 
assist oncology professionals to adapt, develop and enhance their current chemotherapy 
administration procedures and processes. Despite the high standards set, the document takes a 
pragmatic approach that is adaptable to the varied resources and clinical situations of the South 
African oncology context. Improved patient care, patient outcomes and the safety and competency 
of chemotherapy staff are at its heart.
Central to its aims is the promotion of two concepts:
•	 error reduction
•	 safety.
There are no nationally recognised guidelines for the handling and administration of 
chemotherapy in South Africa. The Independent Clinical Oncology Network’s Chemotherapy 
Administration Standards and Guidelines Resource Document was developed over 2 years and first 
introduced at a South African international oncology conference in 2017. A working group 
consisting of oncologists and oncology nurses was set up to address this deficiency. Pragmatic 
guidelines suitable to a wide range of local chemotherapy administration practices were 
developed using an iterative, multidisciplinary, collaborative process. The consensus was that 
these guidelines should be appropriate to the South African context. Safety, standard 
operational procedures, recommended professional competencies and training were central to 
the document. Guidelines for prescribing, storing, mixing, dispensing, administering and 
disposing of chemotherapy were included. Patient consent and involvement, patient and staff 
safety, recommended professional competencies, management of accidents and errors, error 
reporting and local legal requirements are dealt with in detail. The hope is that these guidelines 
will be used as a resource document for South African chemotherapy practices, both public 
and private. The document is supported by standard operating procedures and action steps. 
These were developed to promote the use of the guidelines and to support pragmatic quality 
assurance measures at practice level. These standards and guidelines will be regularly updated, 
based on needs identified and deficiencies noted.
Chemotherapy administration standards  
and guidelines: The development  
of a resource document
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While the goals of chemotherapy are far more than just error 
reduction and safety, these are critical points of departure 
before other goals, such as improved treatment outcomes, 
improved patient experience and staff job satisfaction, can be 
considered.
Error reduction in chemotherapy administration
Chemotherapy administration errors are a recognised issue 
worldwide. Local statistics for chemotherapy administration 
errors are not known. Medical errors rank third amongst the 
most common causes of death in the United States.2 Walsh 
et al.3 observed an error rate of 8.2 per 1000 medication orders 
in adult cancer patients in the outpatient setting, of which 
5/1000 had the potential to cause harm and 1/1000 resulted 
in injury to the patient.
A 2013 study on chemotherapy found a rate of almost 
17 errors per 1000 chemotherapy doses in a sample of 
handwritten orders.4 A study conducted in Turkey found 
that 83% of nurses reported one or more errors during 
chemotherapy preparation and administration.5 Studies have 
shown a wide range of errors including under- and over-
dosing, incorrect medicines used, as well as administration of 
chemotherapy to the wrong patients.6
To reduce errors, and any potential harm caused to patients 
receiving chemotherapy, several aspects were considered in 
the guideline development. These include recommendations 
on appropriate training and competency evaluation of 
all healthcare professionals involved in chemotherapy 
administration, adequate staffing and a clear chemotherapy 
administration process that follows the usual chemotherapy 
patient pathway, with practical checklists for use at critical 
points in this pathway. Standard operating procedures 
(SOPs) for each process were also developed.
In these guidelines emphasis is placed on the fact that 
competency is defined as a measure of the actual ability to 
perform specific duties and not purely a qualification or 
professional title. The SOPs and checklists are designed to be 
practical, comprehensive and useful in the promotion of 
attention to detail at every step of the chemotherapy 
administration pathway.7,8
Safety
Chemotherapy should be given in an environment where 
safety is prioritised.9
The guidelines consider the issue of safety in chemotherapy 
administration as being comprised of the following:
•	 the safety of patients receiving chemotherapy
•	 the safety of professional staff involved in the prescribing, 
storage, handling, preparation, dispensing, disposing 
and administering of chemotherapy.
These guidelines are an attempt to assist diverse practices in 
South Africa develop a culture of safety.
Document development
This document flows out of the quality assurance (QA) 
programme in chemotherapy administration of the 
Independent Clinical Oncology Network (ICON).
Quality assurance in chemotherapy 
administration
Independent Clinical Oncology Network introduced a QA 
programme in all their network chemotherapy facilities in 
2012. This was an adaptation of the national core healthcare 
standards consisting of the domains developed by the Office 
of Health Standards Compliance that came out of the National 
Health Amendment Act of 2013.10 Further adaptions to make 
these domains both relevant and user friendly were made in 
2015.11 This QA programme was modelled on the well-
accepted principles already in place for the high-quality QA 
programmes used in all the network radiotherapy units.12
The use of practical protocols, checklists and SOPs is known 
to reduce errors in medical practice.13,14 For the network 
chemotherapy administration QA programme, the focus was 
on a process-orientated approach. During the implementation 
and review of this process at practice level it became apparent 
that chemotherapy administration guidelines of varying 
standards and utility existed around the country. Professional 
competencies of the staff involved in this process were also 
not standardised.
Oncology nurses in the network identified the lack of 
local practical, standardised chemotherapy administration 
guidelines as problematic and expressed a need for such 
guidelines to assist them in this complex area of medicine.
Based on this feedback it was decided to develop a practical, 
process-orientated and patient-centric guideline resource 
document. The multidisciplinary nature of chemotherapy 
treatment of a cancer patient was recognised as a key element 
in the guidelines design.
Standards and guidelines document 
development
A working group was set up to drive the document 
development process. This group started by undertaking 
wider consultation and interaction with the various 
chemotherapy practices in the network to gauge the need for, 
and interest in, such guidelines. Once the need was confirmed 
the process of data collection started.
The working group’s aim was to collate the best of various 
recognised local and international standards and guidelines 
for the administration of chemotherapy in a single document. 
This was done with the clear brief to ensure that the outcome 
would be a practical, user-friendly guide that was applicable 
and adaptable to the diverse requirements of the South 
African oncology environment.
The initial draft document developed was discussed in 
depth at a workshop at a national oncology conference. 
Page 3 of 6 Practice Guideline
http://www.sajo.org.za Open Access
Following this, a larger working group, taking feedback from 
the workshop, debated the proposed content and layout of 
the guidelines. Based on these discussions and further 
interactions, a final draft document was drawn up. This draft 
was then circulated for input and comment and a final 
iteration was ratified. This document was then published on 
the ICON website for use, feedback and comment within the 
network. Standard operating procedures and checklists 
were then developed to support the main document and are 
available to the network on request.
The working group recognised that modern chemotherapy is 
complex and requires high levels of skill from various 
professions. For this reason, it was felt that the document 
should address the main professions involved in this process 
and that the multidisciplinary team approach needed to be 
highlighted. This dictated the design of the document.
The chemotherapy administration 
multidisciplinary team
Patients receiving chemotherapy are generally managed by a 
team that includes the oncologist, the oncology pharmacist 
and the oncology nurse. The working group felt that the use 
of standardised guidelines by each discipline involved in 
the chemotherapy process, along with good lines of 
communication between disciplines, has a greater potential 
to both reduce the risk of chemotherapy administration 
errors as well as enhance the experience for professionals and 
patients alike.
The guidelines document has had extensive input from 
oncologists and oncology nurses and so currently focusses on 
these two areas. The hope is that South African oncology 
pharmacists will contribute to the completion of this 
document by developing guidelines of their own.
The document also recognises that the chemotherapy patient 
has a central role in the process. For this reason, the document 
focuses on patient education in detail. Issues around 
informed consent, counselling and family inclusion in this 
process are highlighted.
The chemotherapy patient was used as the starting point 
from which the pathway through the whole chemotherapy 
process was developed. This pathway was based on the route 
taken by most patients who receive chemotherapy (Figure 1). 
The document was then developed following this stepwise 
process.
The multidisciplinary process is once again highlighted in 
this pathway. The working group felt it was important to 
promote the concept that chemotherapy administration 
should ideally involve the three trained professional groups 
from different, but complementary, disciplines standardly 
involved in chemotherapy administration. It was felt that 
this cross-disciplinary approach, along with the involvement 
of a well-educated patient, would have the best chance 
of ensuring the reduction of administration errors and 
optimising the patient’s outcome.
While the document describes processes and procedures 
that should be aimed for in the ideal chemotherapy setting, 
we are aware of the limitations and constraints that exist in 
our local environment. The hope is that, while all the 
steps and processes described may not be applicable to all 
chemotherapy practices in South Africa currently, the 
guidelines should be viewed as a starting point in the 
promotion of improved chemotherapy administration 
standards in South Africa.
The document was based on a patient-centric, multidisciplinary 
pathway (Figure 1).
The recommended optimal overall pathway for a patient receiving
chemotherapy in an ICON facility is as follows:
• Patient diagnosed; referred to the oncologist 
   and/or MDT.
• Oncologist and patient discussion concerning
    treatment options, benefits and potential
    side-effects.
• Consultation with the oncologist and/or MDT.
• Oncologist and/or MDT assessment and decision 
   on appropriate treatment options.
• Oncologist and patient consent.
• Oncologist prescribes the treatment regimen.
• Oncology nurse assesses patient prior to
    administration.
• Patient education by oncology nurse.
• Prescription is checked, mixed and dispensed
   by the oncology pharmacist.
• Mixed chemotherapy is checked by two oncology
   nurses.
• Chemotherapy is administered by the oncology
   nurse.
• Patient is given follow-up appointments for further 
   treatment and investigations.
• Patient is given take-home information 
   concerning potential side effects, complications 
   and appropriate emergency contact details.
• Completion of treatment and follow-up
   arrangements.
• Discharge planning.
Oncologist Oncology nurse Oncology pharmacist
Patient
Oncologist/MDT
















 and treatment plan • Further treatment decisions then made by
   oncologist or MDT based on these outcomes.
• Subsequent care plan.
• Patient is monitored for both side effects and
   response to treatment.
ICON, Independent Clinical Oncology Network; MDT, multidisciplinary team.
FIGURE 1: The Chemotherapy Patient Pathway.
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Summary of the contents of the 
Chemotherapy Administration 
Standards and Guidelines 
resource document
The document is divided into three sections:
1. General introduction
2. Role of the oncologist
3. Role of the oncology nurse.
A fourth section relating to the role of the oncology pharmacist 
would complete this document but, as of publication, we 
have not had input from the oncology pharmacist groups.
The ‘General introduction’ addresses the following topics:
•	 Aims and scope of the guidelines
•	 Errors in chemotherapy administration
•	 Current local guidelines for chemotherapy administration
•	 Control of medicines in South Africa
•	 The multidisciplinary nature of chemotherapy administration
•	 Competencies, skills and training
•	 Resources and medical cover
•	 Staff identification and patient confidentiality
•	 Expected basic knowledge.
The ‘Role of the oncologist’ section is further divided into the 
following headings and subheadings:
•	 The scope of practice for the oncologist
 ß General responsibilities
 ß Recommended competencies and skills
•	 The chemotherapy prescription/treatment plan
 ß General and legal principles
 ß Recommended chemotherapy prescription content
 ß Special considerations for oral chemotherapy prescription
•	 Informed consent and patient education
 ß General legal and ethical principles
 ß Recommended content of the informed consent process
 ß Oral chemotherapy – special considerations re consent
 ß Patient’s role in consent and education – the ‘vigilant 
partner’.
Other important areas covered under this section include 
record-keeping according to local legal principles, the 
management and reporting of errors in chemotherapy 
administration, chemotherapy adverse drug reactions and 
chemotherapy administration incidents.
The ‘Role of the oncology nurse’ section is structured to be of 
practical use in the clinical setting.
The introduction details the following:
•	 The complexity of chemotherapy treatment
•	 Risks of personal exposure to chemotherapy drugs
•	 The role of the chemotherapy patient and family.
‘Competencies, skills and training’ highlights the following 
points:
•	 Basic required skills such as venous cannulation and 
central access device care
•	 The oncology nurse’s role in chemotherapy calculations.
The general duties of the oncology nurse are detailed:
•	 Receipt of chemotherapy
•	 Storage of chemotherapy
•	 Management of expired or damaged or contaminated drugs
•	 Preparation area (mixing area)
•	 Chemotherapy prescription
•	 Prescription standards
 ß Prescription check
 ß Verbal orders
 ß New orders
 ß Electronic systems
 ß Prescription double check.
‘Chemotherapy mixing’ looks at topics of importance to 
oncology nurses who mix chemotherapy in the clinic:
•	 Preparation
•	 Recommended personal protective equipment (PPE)
•	 Reconstitution
•	 Labelling of chemotherapy
•	 Issuing
•	 Transportation of chemotherapy
•	 Chemotherapy mixing register.
The central, practical section is titled ‘Chemotherapy 
administration’. This starts by addressing the professional 
values of accountability and competence. It then describes 
the stepwise processes involved in the chemotherapy nurse’s 
management of a cancer patient. To enhance the practical 
nature of this section it is divided into action steps (Box 1).
‘Management of side-effects and adverse events’ during 
chemotherapy administration looks at evidence-based 
approaches to the prevention and management of:
•	 Infusion reactions, hypersensitivity reactions and anaphylaxis
BOX 1: Action steps.
STEP 1.
Pre-chemotherapy patient assessment, education, and informed consent










1.4 Chemotherapy administration process
1.5 Completion of chemotherapy process






Completion of chemotherapy administration records (documentation)
Page 5 of 6 Practice Guideline
http://www.sajo.org.za Open Access
•	 Extravasation
•	 Reporting of chemotherapy adverse drug reactions.
The section on ‘Health and safety’, a core element of these 
guidelines, focuses on both the safety of patients and the 
often unconsidered and unrecognised issue of chemotherapy 
staff health and safety:




 ß Emergency equipment
 ß Administration equipment
B. Worker health and safety
•	 Common routes of exposure
•	 Personal protective equipment
•	 Decontamination, cleaning and disinfection
•	 Worker contamination
•	 Chemotherapy spillage management.
Special attention is given to
•	 Staff medical surveillance:
 ß Routine surveillance
 ß Medical surveillance programmes
 ß Post-contamination surveillance.
The section ‘Management and disposal of cytotoxic waste’, 
an important safety and legal issue, covers the following 
subjects:
•	 Cytotoxic waste disposal
•	 Cytotoxic waste bins
•	 Sharp disposal containers
•	 Additional waste disposal recommendations:
 ß Contaminated disposable equipment
 ß PPE and cleaning equipment
 ß Contaminated non-disposable equipment
 ß Unused oral doses
 ß Patient waste and body fluids.
The oncology nurse guidelines conclude with the important 
topic of documentation.
Incident recording, reporting and management
•	 General principles of incident reporting and management
•	 Examples of incidents
•	 Key requirements for an incident report
•	 Documentation of an incident
•	 Implementation of QA improvements.
Conclusion
The ICON Chemotherapy Administration Standards and 
Guidelines is a single resource document that aims to fill an 
unmet need in local cancer care.15 The non-standardisation or 
paucity of chemotherapy administration standards, processes 
and competencies in South Africa are addressed in this 
document by using a patient-centric, multidisciplinary, 
practical approach.
The safety of both oncology patients receiving chemotherapy 
and staff involved in administering it served as a guiding 
principle.
The hope is that this resource document will support those 
chemotherapy professionals and practices in South Africa 
who expressed the desire to improve their current standards 
of chemotherapy administration.
The development of this document had the central aims of 
promoting improved safety and outcomes for oncology 
patients as well as improving the quality of the working 
environment for chemotherapy professional staff. Although 
the guidelines document aims for the highest of standards, it 
is designed to be adaptable to the varied settings in the South 
African medical environment. Implementation of the action 
steps in the form of appropriately adapted checklists on their 
own could be helpful in promoting a developmental 
improvement in chemotherapy administration safety even in 
resource-constrained environments.
The involvement of local oncology nurses in the development 
of this resource document must be recognised as significant. 
In South Africa, as in most parts of the world, oncology 
nurses play a central role in the complex process of 
chemotherapy administration, cancer patient care and 
ensuring that the highest standards are adhered to.
The guidelines document should be viewed as a work in 
progress with the aim to review and update it on a regular basis.
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